Literature DB >> 31841078

Comparing the Effectiveness of Cognitive Functional Treatment and Lumbar Stabilization Treatment on Pain and Movement Control in Patients With Low Back Pain.

Behrouz Khodadad1, Amir Letafatkar1, Malihe Hadadnezhad1, Sadredin Shojaedin1.   

Abstract

BACKGROUND: The treatment of chronic low back pain (LBP) should target both behavioral variables and physical performance factors. HYPOTHESIS: Cognitive functional treatment (CFT) and lumbar stabilization treatment (LST) will result in positive changes in pain and lumbar movement control (LMC) in patients with LBP. STUDY
DESIGN: Pretest-posttest intervention. LEVEL OF EVIDENCE: Level 3.
METHODS: After screening, 52 participants (mean age, 44.3 ± 2.46 years) with chronic LBP were allocated into CFT (n = 17), LST (n = 17), or control (n = 18) groups. Pain and LMC were evaluated before and after 8 weeks of intervention with visual analog scale (VAS) and Luomajoki LMC battery tests, respectively.
RESULTS: Compared with baseline, pain and LMC were reduced and improved significantly in both groups after 8 weeks. However, the changes in both variables were not significantly different between groups. Percent change for pain between pretest and posttest values in the LST group was a decrease of 45% (P = 0.003), compared with a decrease of 40% (P = 0.003) in the CFT group. Change in LMC in the LST group was a decrease of 100% (P = 0.026), compared with a decrease of 200% (P = 0.018) in the CFT group. There as no change for both variables in the control group.
CONCLUSION: Both CFT and LST groups improved LMC scores and reduced pain intensity. However, there was no difference between the 2 experimental groups on pain and LMC test results. CLINICAL RELEVANCE: In this study, intended to construct an intervention for people with chronic LBP, the primary aims were to help individuals "make sense of their pain," develop effective pain control strategies via body relaxation and extinction of safety behaviors, and adopt healthy lifestyle behaviors to affect cognitive factors known to affect pain sensitivity and disability. These primary aims were achieved through an emphasis on factors such as development of positive beliefs, reduced fear, increased awareness, enhanced understanding and control of pain, adaptive coping, enhanced self-efficacy, confidence, and improved mood through the class-based intervention.

Entities:  

Keywords:  back pain; cognitive therapy; education; lumbar movement control; lumbar stabilization treatment

Mesh:

Year:  2019        PMID: 31841078      PMCID: PMC7222662          DOI: 10.1177/1941738119886854

Source DB:  PubMed          Journal:  Sports Health        ISSN: 1941-0921            Impact factor:   3.843


  22 in total

Review 1.  The Roland-Morris Disability Questionnaire and the Oswestry Disability Questionnaire.

Authors:  M Roland; J Fairbank
Journal:  Spine (Phila Pa 1976)       Date:  2000-12-15       Impact factor: 3.468

Review 2.  A systematic review of psychological factors as predictors of chronicity/disability in prospective cohorts of low back pain.

Authors:  Tamar Pincus; A Kim Burton; Steve Vogel; Andy P Field
Journal:  Spine (Phila Pa 1976)       Date:  2002-03-01       Impact factor: 3.468

3.  The stabilizing system of the spine. Part I. Function, dysfunction, adaptation, and enhancement.

Authors:  M M Panjabi
Journal:  J Spinal Disord       Date:  1992-12

Review 4.  Diagnosis and classification of chronic low back pain disorders: maladaptive movement and motor control impairments as underlying mechanism.

Authors:  Peter O'Sullivan
Journal:  Man Ther       Date:  2005-09-09

5.  Intensive dynamic back exercises for chronic low back pain: a clinical trial.

Authors:  Claus Manniche; Eva Lundberg; Inge Christensen; Lis Bentzen; Grete Hesselsøe
Journal:  Pain       Date:  1991-10       Impact factor: 6.961

6.  Low back pain and best practice care: A survey of general practice physicians.

Authors:  Christopher M Williams; Christopher G Maher; Mark J Hancock; James H McAuley; Andrew J McLachlan; Helena Britt; Salma Fahridin; Christopher Harrison; Jane Latimer
Journal:  Arch Intern Med       Date:  2010-02-08

7.  The validation of visual analogue scales as ratio scale measures for chronic and experimental pain.

Authors:  Donald D Price; Patricia A McGrath; Amir Rafii; Barbara Buckingham
Journal:  Pain       Date:  1983-09       Impact factor: 6.961

Review 8.  Opioids compared to placebo or other treatments for chronic low-back pain.

Authors:  Luis Enrique Chaparro; Andrea D Furlan; Amol Deshpande; Angela Mailis-Gagnon; Steven Atlas; Dennis C Turk
Journal:  Cochrane Database Syst Rev       Date:  2013-08-27

9.  Efficacy of classification-based cognitive functional therapy in patients with non-specific chronic low back pain: a randomized controlled trial.

Authors:  K Vibe Fersum; P O'Sullivan; J S Skouen; A Smith; A Kvåle
Journal:  Eur J Pain       Date:  2012-12-04       Impact factor: 3.931

Review 10.  The Influence of Physical Therapy Guideline Adherence on Healthcare Utilization and Costs among Patients with Low Back Pain: A Systematic Review of the Literature.

Authors:  William J Hanney; Michael Masaracchio; Xinliang Liu; Morey J Kolber
Journal:  PLoS One       Date:  2016-06-10       Impact factor: 3.240

View more
  3 in total

1.  Popular videos related to low back pain on YouTube™ do not reflect current clinical guidelines: a cross-sectional study.

Authors:  Laísa B Maia; Juliana P Silva; Mateus B Souza; Nicholas Henschke; Vinicius C Oliveira
Journal:  Braz J Phys Ther       Date:  2021-07-16       Impact factor: 3.377

Review 2.  Efficacy of Core Stability in Non-Specific Chronic Low Back Pain.

Authors:  Antonio Frizziero; Giacomo Pellizzon; Filippo Vittadini; Davide Bigliardi; Cosimo Costantino
Journal:  J Funct Morphol Kinesiol       Date:  2021-04-22

3.  Dose-response-relationship of stabilisation exercises in patients with chronic non-specific low back pain: a systematic review with meta-regression.

Authors:  Juliane Mueller; Daniel Niederer
Journal:  Sci Rep       Date:  2020-10-09       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.